» Authors » Claudio Villarroel

Claudio Villarroel

Explore the profile of Claudio Villarroel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 201
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Henriquez S, Valdivia M, Mainigi M, Villarroel C, Velasquez L, Strauss Iii J, et al.
Steroids . 2024 Jan; 203:109368. PMID: 38278282
Estrogens produced by the ovary play diverse roles in controlling physiological changes in the function of the female reproductive system. Although estradiol acts through classical nuclear receptors, its metabolites (EMs)...
2.
Al-Hendy A, Lukes A, Venturella R, Villarroel C, McKain L, Li Y, et al.
J Comp Eff Res . 2023 Jul; 12(8):e230069. PMID: 37477173
What is this summary about? This is a summary of a research study (known as a clinical trial) called the LIBERTY extension study. The LIBERTY extension study is a long-term...
3.
Al-Hendy A, Lukes A, Poindexter 3rd A, Venturella R, Villarroel C, Critchley H, et al.
Pain Manag . 2023 May; 13(4):205-211. PMID: 37183454
What Is This Summary About?: This is a summary of research studies (known as clinical trials) called LIBERTY 1 and LIBERTY 2. The LIBERTY 1 and LIBERTY 2 studies looked...
4.
Al-Hendy A, Lukes A, Poindexter 3rd A, Venturella R, Villarroel C, McKain L, et al.
Obstet Gynecol . 2022 Nov; 140(6):920-930. PMID: 36357960
Objective: In the LIBERTY 1 and LIBERTY 2 placebo-controlled trials, once-daily relugolix combination therapy reduced menstrual blood loss volume and pain in women with heavy menstrual bleeding associated with uterine...
5.
Al-Hendy A, Lukes A, Poindexter 3rd A, Venturella R, Villarroel C, Critchley H, et al.
N Engl J Med . 2021 Feb; 384(7):630-642. PMID: 33596357
Background: Uterine fibroids are a common cause of heavy menstrual bleeding and pain. Treatment with the combination of relugolix (an oral gonadotropin-releasing hormone-receptor antagonist), estradiol, and norethindrone acetate, administered once...
6.
Henriquez S, Kohen P, Xu X, Villarroel C, Munoz A, Godoy A, et al.
Hum Reprod . 2020 Jun; 35(7):1655-1665. PMID: 32558920
Study Question: Do alterations in pro- and anti-angiogenic estrogen metabolites in follicular fluid (FF) contribute to the follicular growth arrest and anovulation associated with polycystic ovary syndrome (PCOS)? Summary Answer:...
7.
Bahamondes L, Villarroel C, Frias Guzman N, Oizerovich S, Velazquez-Ramirez N, Monteiro I
Hum Reprod Open . 2019 Mar; 2018(1):hox030. PMID: 30895242
Study Question: Can the high rate and associated burden of unintended pregnancy (UP) and adolescent pregnancy in Latin America and the Caribbean (LAC) be reduced through wider access to and...
8.
Merino P, Villarroel C, Jesam C, Lopez P, Codner E
Horm Res Paediatr . 2017 Oct; 88(6):401-407. PMID: 29049986
Background: The ultrasonographic criteria used to identify polycystic ovarian morphology (PCOM) during adolescence have changed over time. Recently, a Worldwide Pediatric Consensus (PedC) defined PCOM using stricter criteria than the...
9.
Villarroel C, Salinas A, Lopez P, Kohen P, Rencoret G, Devoto L, et al.
Gynecol Endocrinol . 2017 Aug; 34(2):120-124. PMID: 28758808
Hyperandrogenemia and hyperinsulinemia are observed in women with diabetes during pregnancy. The effect of diabetes on anti-Müllerian hormone (AMH) levels during pregnancy is unclear. The aim of this study was...
10.
Hernandez M, Lopez P, Gaete X, Villarroel C, Cavada G, Avila A, et al.
J Pediatr Endocrinol Metab . 2017 Jun; 30(5):561-568. PMID: 28593921
Background: During puberty there is a physiologic increase in adrenal and ovarian androgens. It has been suggested that the somatotrophic axis may be related to the development of hyperandrogenism and...